Aia Group LTD Abb Vie Inc. Transaction History

Aia Group LTD

$4.23 Billion
Q2 2025

A detailed history of Aia Group LTD transactions in Abb Vie Inc. stock. As of the latest transaction made, Aia Group LTD holds 11,542 shares of ABBV stock, worth $2.63 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

11,542

Previous 23,828 51.56%

Holding current value

$2.63 Million

Previous $4.99 Million 57.09%

% of portfolio

0.05%

Previous 0.13%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 06, 2025	SELL	$170.16 - $206.27 $2.09 Million - $2.53 Million	-12,286 Reduced 51.56%	11,542 $2.14 Million
Q1 2025 May 12, 2025	SELL	$169.2 - $216.66 $132,991 - $170,294	-786 Reduced 3.19%	23,828 $4.99 Million
Q4 2024 Feb 12, 2025	SELL	$164.99 - $203.87 $2.06 Million - $2.54 Million	-12,459 Reduced 33.61%	24,614 $4.37 Million
Q3 2024 Oct 31, 2024	SELL	$163.84 - $199.33 $1.78 Million - $2.16 Million	-10,861 Reduced 22.66%	37,073 $7.32 Million
Q2 2024 Jul 31, 2024	BUY	$154.79 - $180.76 $609,717 - $712,013	3,939 Added 8.95%	47,934 $8.22 Million
Q1 2024 May 06, 2024	BUY	$159.82 - $182.1 $5.16 Million - $5.88 Million	32,295 Added 276.03%	43,995 $8.01 Million
Q4 2023 Jan 31, 2024	BUY	$137.6 - $154.97 $481,462 - $542,240	3,499 Added 42.67%	11,700 $1.81 Million
Q3 2023 Nov 01, 2023	BUY	$133.59 - $154.65 $1.1 Million - $1.27 Million	8,201 New	8,201 $1.22 Million
Q1 2023 Apr 28, 2023	SELL	$144.61 - $166.54 $571,354 - $657,999	-3,951 Reduced 12.32%	28,131 $4.48 Million
Q4 2022 Jan 31, 2023	BUY	$138.31 - $165.87 $2.11 Million - $2.53 Million	15,249 Added 90.59%	32,082 $5.19 Million
Q3 2022 Nov 04, 2022	SELL	$134.21 - $153.93 $2.22 Million - $2.55 Million	-16,569 Reduced 49.6%	16,833 $2.26 Million
Q2 2022 Aug 11, 2022	BUY	$137.62 - $174.96 $784,296 - $997,097	5,699 Added 20.57%	33,402 $5.12 Million
Q1 2022 May 06, 2022	SELL	$131.98 - $163.75 $215,127 - $266,912	-1,630 Reduced 5.56%	27,703 $4.49 Million
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $2.34 Million - $2.96 Million	21,791 Added 288.93%	29,333 $3.97 Million
Q3 2021 Nov 05, 2021	SELL	$106.4 - $120.78 $716,391 - $813,211	-6,733 Reduced 47.17%	7,542 $814,000
Q2 2021 Aug 03, 2021	BUY	$105.21 - $117.21 $357,293 - $398,045	3,396 Added 31.22%	14,275 $1.65 Million
Q1 2021 May 14, 2021	BUY	$102.3 - $112.62 $457,690 - $503,861	4,474 Added 69.85%	10,879 $1.18 Million
Q4 2020 Feb 12, 2021	BUY	$80.49 - $108.67 $515,538 - $696,031	6,405 New	6,405 $685,000

Others Institutions Holding ABBV

# of Institutions

4,372

Shares Held

1.3B

Call Options Held

16.1M

Put Options Held

10.9M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $403B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aia Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Aia Group LTD with notifications on news.

Account